WCN26-5450 MODULATION OF COMPLEMENT AND COAGULATION PATHWAYS BY NICOTINAMIDE IN RENAL FIBROSIS

Read full text Summarise with VIRAT
Authors: Yuji Oe, Saori Kin, Taku Obara, Emiko Sato, Nobuyuki Takahashi, Mariko Miyazaki, Tetsuhiro Tanaka
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Coagulation and complement systems interact, promoting inflammation and thrombosis, yet their involvement in chronic kidney disease (CKD) is not fully understood. This study aimed to clarify the relationship between the prothrombotic state and complement activity in the pathogenesis of CKD by studying a CKD cohort, public databases, and mouse models of kidney fibrosis. In addition, the therapeutic significance of nicotinamide (NAM), a precursor of NAD+ precursor with anti-inflammatory and antithrombotic properties, in modulating these pathways was demonstrated.

Fields of Study & Subjects

Complement system in diseases Chronic Kidney Disease and Diabetes Blood Coagulation and Thrombosis Mechanisms

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
105381–105381
Publication date
25 March 2026
Language
EN